Csenge Advisory Group’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-4,482
| Closed | -$231K | – | 639 |
|
|
2022
Q2 | $231K | Buy |
4,482
+1,100
| +33% | +$56.7K | 0.02% | 508 |
|
|
2022
Q1 | $249K | Buy |
3,382
+930
| +38% | +$68.5K | 0.02% | 544 |
|
|
2021
Q4 | $529K | Sell |
2,452
-1,195
| -33% | -$258K | 0.05% | 331 |
|
|
2021
Q3 | $662K | Buy |
3,647
+1,195
| +49% | +$217K | 0.06% | 303 |
|
|
2021
Q2 | $529K | Hold |
2,452
| – | – | 0.05% | 332 |
|
|
2021
Q1 | $441K | Buy |
2,452
+302
| +14% | +$54.3K | 0.05% | 305 |
|
|
2020
Q4 | $240K | Hold |
2,150
| – | – | 0.03% | 373 |
|
|
2020
Q3 | $231K | Buy |
+2,150
| New | +$231K | 0.03% | 354 |
|
|
2018
Q4 | – | Sell |
-25
| Closed | – | – | 1054 |
|
|
2018
Q3 | $0 | Buy |
+25
| New | – | ﹤0.01% | 1422 |
|